Ulixertinib (BVD-523) Ulixertinib inhibitor targeting ERK1/2 in KRAS-Driven Metastatic Pancreatic Cancer

BPTES from Selleck Targets Kidney-Type Glutaminase via Micellar Formulations for Cancer Therapy

4-PBA (4-Phenylbutyric acid) Attenuates Endoplasmic Reticulum Stress in Shock

Cyclopamine (11-Deoxojervine) and Cyclopamine from Selleck Block Smoothened Signaling in Myopia

Vismodegib (GDC-0449) targets cyclooxygenase-2 to suppress prostaglandin E2 synthesis in inflammatory models

SAG (Smoothened Agonist) Visual Arrestin Mutations in Oguchi Disease Type 1

Purmorphamine Selectively Activates Frizzled 6 Biased Signaling via Seven-Transmembrane Core Pocket Engagement

C646 from Selleck targets p300/CBP histone acetyltransferase for antiviral drug repositioning